102 related articles for article (PubMed ID: 33651452)
21. Psychological Alterations in Youths with Type I Diabetes: Associations with Salivary Cortisol Concentration.
El Mlili N; Ahabrach H; Bahri H; Kerkeb A; Mafla-España MA; Cauli O
Medicina (Kaunas); 2023 Dec; 60(1):. PubMed ID: 38276053
[No Abstract] [Full Text] [Related]
22. Hope and mealtime insulin boluses are associated with depressive symptoms and glycemic control in youth with type 1 diabetes mellitus.
Calkins-Smith AK; Marker AM; Clements MA; Patton SR
Pediatr Diabetes; 2018 Nov; 19(7):1309-1314. PubMed ID: 29797445
[TBL] [Abstract][Full Text] [Related]
23. The prevalence of attention-deficit/hyperactivity disorder following neonatal aortic arch repair.
Sistino JJ; Atz AM; Simpson KN; Ellis C; Ikonomidis JS; Bradley SM
Cardiol Young; 2015 Apr; 25(4):663-9. PubMed ID: 24775274
[TBL] [Abstract][Full Text] [Related]
24. Structured, intensive education maximising engagement, motivation and long-term change for children and young people with diabetes: a cluster randomised controlled trial with integral process and economic evaluation - the CASCADE study.
Christie D; Thompson R; Sawtell M; Allen E; Cairns J; Smith F; Jamieson E; Hargreaves K; Ingold A; Brooks L; Wiggins M; Oliver S; Jones R; Elbourne D; Santos A; Wong IC; O'Neill S; Strange V; Hindmarsh P; Annan F; Viner R
Health Technol Assess; 2014 Mar; 18(20):1-202. PubMed ID: 24690402
[TBL] [Abstract][Full Text] [Related]
25. Sleep quality in children and adolescents with attention-deficit and hyperactivity disorder.
Yıldız Miniksar D; Özdemir M
Arch Pediatr; 2021 Nov; 28(8):668-676. PubMed ID: 34688509
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of sleep disorders and their relationship with core symptoms of inattention and hyperactivity in children with attention-deficit/hyperactivity disorder.
Vélez-Galarraga R; Guillén-Grima F; Crespo-Eguílaz N; Sánchez-Carpintero R
Eur J Paediatr Neurol; 2016 Nov; 20(6):925-937. PubMed ID: 27461837
[TBL] [Abstract][Full Text] [Related]
27. Family Support and Its Association with Glycemic Control in Adolescents with Type 1 Diabetes Mellitus in Riyadh, Saudi Arabia.
AlHaidar AM; AlShehri NA; AlHussaini MA
J Diabetes Res; 2020; 2020():5151604. PubMed ID: 32280715
[TBL] [Abstract][Full Text] [Related]
28. [Health-related quality of life in cases of attention deficit hyperactivity disorder with and without pharmacological treatment].
López-Villalobos JA; Sacristán-Martín AM; Garrido-Redondo M; Martínez-Rivera MT; López-Sánchez MV; Rodríguez-Molinero L; Camina-Gutiérrez AB; Andrés-de Llano J
An Pediatr (Engl Ed); 2019 May; 90(5):272-279. PubMed ID: 29871841
[TBL] [Abstract][Full Text] [Related]
29. Attention-deficit/hyperactivity disorder and obesity in US males and females, age 8-15 years: National Health and Nutrition Examination Survey 2001-2004.
Byrd HC; Curtin C; Anderson SE
Pediatr Obes; 2013 Dec; 8(6):445-53. PubMed ID: 23325553
[TBL] [Abstract][Full Text] [Related]
30. Daily life impairments associated with self-reported childhood/adolescent attention-deficit/hyperactivity disorder and experiences of diagnosis and treatment: results from the European Lifetime Impairment Survey.
Caci H; Doepfner M; Asherson P; Donfrancesco R; Faraone SV; Hervas A; Fitzgerald M
Eur Psychiatry; 2014 Jun; 29(5):316-23. PubMed ID: 24355601
[TBL] [Abstract][Full Text] [Related]
31. The association between attention deficit hyperactivity disorder severity and risk of mild traumatic brain injury in children with attention deficit hyperactivity disorder in the United States of America: A cross-sectional study of data from the National Survey of Children with Special Health Care Needs.
Karic S; DesRosiers M; Mizrahi B; Zevallos J; Rodriguez P; Barengo NC
Child Care Health Dev; 2019 Sep; 45(5):688-693. PubMed ID: 31049988
[TBL] [Abstract][Full Text] [Related]
32. Association between quality of life and treatment response in children with attention Deficit Hyperactivity Disorder and their parents.
van der Kolk A; Bouwmans CA; Schawo SJ; Buitelaar JK; van Agthoven M; Hakkaart-van Roijen L
J Ment Health Policy Econ; 2014 Sep; 17(3):119-29. PubMed ID: 25543115
[TBL] [Abstract][Full Text] [Related]
33. Caregivers' distress: youth with attention-deficit/hyperactivity disorder and comorbid disorders assessed via telemental health.
Rockhill C; Violette H; Vander Stoep A; Grover S; Myers K
J Child Adolesc Psychopharmacol; 2013 Aug; 23(6):379-85. PubMed ID: 23952184
[TBL] [Abstract][Full Text] [Related]
34. Health related quality of life in pediatric onset Type 1 diabetes mellitus in Kerala, India.
Bhavani N; Prince S; Menon AS; Abraham N; Pavithran PV; Menon UV; Nair V; Kumar H
Pediatr Diabetes; 2021 Mar; 22(2):369-373. PubMed ID: 33180987
[TBL] [Abstract][Full Text] [Related]
35. The adolescent outcome of children with attention deficit hyperactivity disorder treated with methylphenidate or methylphenidate combined with multimodal behaviour therapy: results of a naturalistic follow-up study.
van der Oord S; Prins PJ; Oosterlaan J; Emmelkamp PM
Clin Psychol Psychother; 2012; 19(3):270-8. PubMed ID: 21404369
[TBL] [Abstract][Full Text] [Related]
36. Heterotypic trajectories of dimensional psychopathology across the lifespan: the case of youth-onset attention deficit/hyperactivity disorder.
Manfro AG; Santoro M; Polanczyk GV; Gadelha A; Pan PM; Bressan RA; Brietzke E; Talarico F; Belangero S; Rohde LA; Salum GA
J Child Psychol Psychiatry; 2019 May; 60(5):533-544. PubMed ID: 30329156
[TBL] [Abstract][Full Text] [Related]
37. Continuous subcutaneous insulin infusion benefits quality of life in preschool-age children with type 1 diabetes mellitus.
Opipari-Arrigan L; Fredericks EM; Burkhart N; Dale L; Hodge M; Foster C
Pediatr Diabetes; 2007 Dec; 8(6):377-83. PubMed ID: 18036064
[TBL] [Abstract][Full Text] [Related]
38. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
Yang P; Hsu HY; Chiou SS; Chao MC
Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
[TBL] [Abstract][Full Text] [Related]
39. Prospective Analysis of the Impact of Commercialized Hybrid Closed-Loop System on Glycemic Control, Glycemic Variability, and Patient-Related Outcomes in Children and Adults: A Focus on Superiority Over Predictive Low-Glucose Suspend Technology.
Beato-Víbora PI; Gallego-Gamero F; Lázaro-Martín L; Romero-Pérez MDM; Arroyo-Díez FJ
Diabetes Technol Ther; 2020 Dec; 22(12):912-919. PubMed ID: 31855446
[No Abstract] [Full Text] [Related]
40. Fitness and physical activity in youth with type 1 diabetes mellitus in good or poor glycemic control.
Nguyen T; Obeid J; Walker RG; Krause MP; Hawke TJ; McAssey K; Vandermeulen J; Timmons BW
Pediatr Diabetes; 2015 Feb; 16(1):48-57. PubMed ID: 24444038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
